Category: Health Updates
-

Mexico exploring phase 3 trials of Russian coronavirus vaccine
MEXICO CITY (Reuters) – Mexico told Moscow on Wednesday it would like to carry out phase 3 testing of Russia’s coronavirus vaccine, as part of the Latin American country’s intensifying efforts to secure early supplies of an effective medicine to control the pandemic. After a meeting with Russia’s ambassador to Mexico, Viktor Koronelli, Foreign Minister…
-

Covid-19 vaccine trials have been slow to recruit Black and Latino people — and that could delay a vaccine
The multi-billion-dollar effort to get a coronavirus vaccine on the market could see delays because researchers haven’t recruited sufficient numbers of minorities to join the clinical trials. Of the 350,000 people who’ve registered online for a coronavirus clinical trial, 10% are Black or Latino, according to Dr. Jim Kublin, executive director of operations for the Covid-19…
-

COVID-19 Vaccine Will Be Free for All Americans, Official Says U.S. ‘on Track’ to Deliver Doses by January 2021
A federal official announced on Thursday that a COVID-19 vaccine will be free for all Americans. “We are on track to deliver hundreds of millions of doses by January 2021,” Paul Mango, a senior health department official, told reporters. The government has invested more than $10 billion in six vaccine projects. If a vaccine is…
-

Don’t Delay Your Child’s Vaccinations, Especially Now
August is the time when families with school-aged children prepare for the start of another academic year. This usually means shopping for supplies, clothes and shoes for growing girls and boys—and a visit to a health care provider for annual exams, sports physicals and recommended vaccines. August is even National Immunization Awareness Month to coincide…
-

Japan to agree supply deal soon for AstraZeneca’s coronavirus vaccine
The Japanese government will soon agree a supply deal for more than 100 million doses of a coronavirus vaccine being developed by AstraZeneca Plc (AZN.L), Kyodo news agency reported on Friday. The British drugmaker has been in talks with Japan, Russia, Brazil and others about supply deals for its potential coronavirus vaccine, known as AZD1222.…
-

Trump says coronavirus vaccine possible before Nov. 3
U.S. President Donald Trump said on Thursday it was possible the United States would have a coronavirus vaccine before the Nov. 3 election, a more optimistic forecast on timing than anything suggested by his own White House health experts. Asked on the Geraldo Rivera radio program when a vaccine might be ready, Trump said, “Sooner…
-

Hikma starts manufacturing COVID-19 drug remdesivir for Gilead
Hikma Pharmaceuticals has started manufacturing remdesivir, an approved treatment for COVID-19 from U.S.-based Gilead, for an undisclosed amount at its facility in Portugal, the British company’s chief executive officer said. It will supply the first batches of the antiviral drug “soon,” and Gilead is expected to distribute the treatment, CEO Siggi Olafsson told Reuters on…
-

Coronavirus kills Florida girl, 9, youngest to die of COVID-19 in state
The novel coronavirus has claimed the life of a young Florida girl, with her death marking the youngest COVID-19-related fatality in the state to date, according to health officials. The girl, who was not identified, was from Putnam County and died from complications related to the deadly virus, local news station WFLA reported, citing the Florida Health…
-

German coronavirus studies identify heart issues in COVID-19 patients
New studies from Germany revealed heart inflammation in recovered coronavirus patients and virus presence in the hearts of those who died from the disease. Both studies called for further investigations of long-term cardiac consequences of COVID-19. One observational study involved 100 patients with recent COVID-19 illness. Cardiac magnetic resonance (CMR) imaging revealed cardiac involvement in 78 patients and heart muscle inflammation in…
-

Potential COVID-19 vaccine would protect obese adults less
Scientists suspect that a potential COVID-19 vaccine would be less effective in protecting obese Americans from the disease, which has infected millions worldwide and killed more than 157,000 in the U.S. alone. In a new report from CNN and Kaiser Health News, researchers pointed out that other prominent vaccines dating back to 1985 — like those for the flu and hepatitis A and hepatitis B —…